GSK CEO : "THE GREAT GROWTH THAT WE HAVE REPORTED THIS YEAR IS VOLUME DRIVEN - IT IS DEMAND DRIVEN - THAT'S ALSO WHY WE'RE OPTIMISTIC ABOUT THE OUTLOOK."